Goodwin Procter LLP advised Therapeutics Acquisition Corp on the deal. Therapeutics Acquisition Corp. closed its initial public offering of 13,570,000 shares of Class A common stock,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now